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Abstract – In Taiwan, the first human case of cat-scratch disease (CSD) was diagnosed by a
serologic test in 1998. Since then, no studies have been conducted to understand the epidemiology
of the infection in Taiwan. Therefore, this study is the first epidemiologic survey of CSD in cats and
humans in this country. Using veterinary-associated individuals as the study population, it was
identified that 1.7% of them were seropositive for B. henselae, and residence was the only factor
associated with seropositivity. Bartonella species were successfully isolated from 25 (19.1%) of the
131 cats tested. Only B. henselae and B. clarridgeiae were obtained from bacteremic cats.
Furthermore, 9.2% of 131 cats were dually-infected with genotypes I and II of B. henselae. It is the
highest prevalence of co-infection that has ever been reported worldwide. In cats, the
seroprevalence was 23.7% by indirect immunofluorescence antibody assay with B. henselae
Houston-1 (type I) as the antigen. When 12 bacteremic but seronegative cats were re-tested by IFA
slides coated with B. henselae U-4 antigen (type II), 9 cats were identified to be seropositive. Our
study further suggested that using only direct PCR of 16S-23S rRNA intergenic region or the
combination of the PCR method and indirect immuno-fluorescence test will be useful to diagnose
Bartonella-free cats. 
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1. INTRODUCTION
Cat-Scratch Disease (CSD) is a zoonosis
as domestic cats are the natural reservoir of
this disease [18]. Bartonella henselae is the
major causative agent of CSD [1, 9, 10, 33].
Though B. clarridgeiae has not been iso-
lated from CSD suspected patients up to
date, the species is considered to be another
possible agent of CSD, based on serological
findings [19, 23]. The first CSD case in Tai-
wan was reported in 1998 [22]. Neverthe-
less, the official reference laboratory for
CSD diagnosis was not established until
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2001 in this country. Until now, no epide-
miologic survey was conducted to under-
stand the risks associated with CSD in cats
and humans in Taiwan. 
B. henselae transmission among cats is
through the exposure of cat flea, Cteno-
cephalides felis [7, 18]. Humans are infected
when cat-scratch or bite-wounds are con-
taminated with feces excreted by infected
cat fleas [12, 14]. Given this fact, veterinary
professionals seem to be a high-risk popula-
tion and need to be investigated. Surprisingly,
there have not been many epidemiologic
studies worldwide on CSD in veterinary-
associated populations. The first epidemio-
logic survey was conducted in veterinarians
from the USA [30]. In that study, 6.0% (18/
198) of responding veterinarians self-
reported a previous diagnosis of CSD, and
3 out of these 18 individual were seroposi-
tive for Bartonella. Furthermore, year of
experience with cats was the only identified
variable associated with seropositivity [30].
There were also two serological investiga-
tions in veterinary populations in Japan [17,
20]. Kumasaka et al. [20] reported that 15%
(35/233) of veterinary professionals were
seropositive for B. henselae, and young
female veterinary assistants and animal
beauticians were more likely to be infected.
Kikuchi et al. [17] reported that 10.9% (14/
129) and 0.8% (1/129) of healthy veterinary
students were IgG- and IgM-positive for
B. henselae, respectively. History of cat-
exposure was the main risk factor in this
study population [17]. 
Bartonella infection in cats has been
reported from many countries in the world
[5]. In Asian countries, the results showed
that seroprevalence of B. henselae among
cat populations in Japan ranged from 9.1 to
15.1% [28, 36], 68% in Philippines [8], 48%
in Singapore [29] and 54% in Indonesia
[24]. Both B. henselae and B. clarridgeiae
have been isolated from cats in some of
these countries, including Indonesia, Thai-
land, Philippines and Japan [8, 24, 26, 27].
The prevalence of bacteremia ranged from
6.4% to 89% for B. henselae [8, 25–27] and
0.7% to 31% for B. clarridgeiae [8, 26, 27].
Co-infection with B. henselae and B. clar-
ridgeiae were reported in cats from the Phi-
lippines and Japan [8, 26]. Taiwan is located
in the subtropical area, with an average tem-
perature of 22.02 °C and relative humidity
of 77.8%, according to the monitoring
record of the Central Weather Bureau, Tai-
wan in 2004. Such an environment is very
suitable for growth of fleas, and flea-
infested animals, such as stray cats and
dogs, are commonly seen all year round.
However, there has been no epidemiologic
investigation on Bartonella infection in cats
in Taiwan until now.
In order to elucidate the epidemiologic
distribution of CSD in cats and humans in
Taiwan, one major objective of this study
was to determine the prevalence and risk
factors of CSD in veterinary-associated
populations. The other objective of the
study was to perform a survey in various cat
populations to understand which Bartonella
species is the most prevalent and factors
associated with the infection in cats in Taiwan.
2. MATERIALS AND METHODS
2.1. Collection of specimens from 
humans
A total of 295 human samples were col-
lected from veterinary-associated popula-
tions in Taiwan, including 195 whole blood
samples and 100 serum samples. The whole
blood samples were from 114 volunteers
attending a Veterinary Conference in 2002
in Taiwan, and 81 people working at the
Veterinary Teaching Hospital of the
National Chung Hsing University between
September and October, 2002. One hundred
serum samples that were originally collected
to be tested for leptospiral infection in vet-
erinary professionals, including 29 clinicians,
55 veterinary students and 16 veterinary
technicians at National Taiwan University
in March, 2002, were also tested for Bartonella
infection. All subjects were administered a
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structured questionnaire to gather demo-
graphic, occupational and associated expo-
sure information.
2.2. Collection of specimens from cats
A total of 131 cat samples were collected
between March 2001 and May 2003. The
cats were from 3 different cat populations
in Taiwan, including 30 pet cats, 37 cats
from a breeding cat farm in Tainan county
and 64 impound cats from a municipal stray
animal shelter in Taipei. The breeding cat
farm was selected for comparison because
its raising environment was under strict
ectoparasite control. One to two milliliters
of whole blood from each cat were collected
in plastic EDTA tubes (Greiner Bio-One
VACUETTE® North America, USA) from
jugular or saphenous vein. Whole blood
samples were centrifuged at 1000× g to sep-
arate the plasma and blood cells. Sera were
prepared from plasma after full speed cen-
trifugation. All samples were frozen at
–70 °C before tested. For the pet cats and
cats from the breeding farm, descriptive
data such as age, sex, neutering history, flea
infestation condition of the cats were
recorded by investigators through inter-
viewing. In impounded cats, the descriptive
data, including estimated age, sex, and flea
infestation were recorded by the same
investigator at the time of blood sampling.
2.3. Detection of Bartonella genomic 
DNA from human and cat blood
The QIAamp® DNA Blood mini Kit
(QIAGEN Inc., Valencia, CA, USA) was
used for extraction of DNA from 200 µL of
human and cat blood samples. Forty-four
cats and 107 human blood specimens were
tested by a single step PCR assay aiming at
the 16S-23S rRNA intergenic region, as
previously described [16]. Forty-four cats
were selected from 131 cats by simple ran-
dom sampling using a table of random
number digits, for blind evaluation of sen-
sitivity, specificity, positive predictive
value and negative predictive value of the
PCR test. A total of 107 human whole blood
samples were analyzed because of having
enough amount of blood for DNA extrac-
tion and PCR analysis. Only whole blood
samples were used for DNA extraction.
Therefore, serum collected from people for
the investigation of leptospirosis were not
used for PCR assay. The primer set used in
amplification of 16S-23S rRNA intergenic
region by a single step PCR assay was
BSSPF (5’-CTC TTT CTT CAG ATG ATG
ATC C-3’) and BSSPR (5’-AAC CAA CTG
AGC TAC AAG CCC T-3’). DNA ampli-
fication was performed with PCRExpress
thermo cycler (HYBAID, Ashford, UK) by
the following PCR protocol: 10 min of incu-
bation at 20 °C, followed by 2 min of dena-
turation at 95 °C and then 45 cycles of 1 min
of denaturation at 95 °C, 1 min of annealing
at 60 °C, and 30 s of extension at 72 °C. PCR
amplification products were identified by
ethidium bromide fluorescence after electro-
phoresis in 3% agarose gels. As described
previously by Jensen et al. [15], the amplified
fragment was 202 bp for B. bacilliformis,
145 bp for B. clarridgeiae, 232 bp for
B. elizabethae, 163 bp for B. henselae,
148 bp for B. quintana, 251 bp for B. vin-
sonii subsp. berkhoffii.
2.4. Isolation of Bartonella spp. in cats
After thawing, 100 µL of the blood was
inoculated onto two chocolate agar plates
(Creative Microbiologicals LTD., Taipei,
Taiwan) and incubated at 35 °C, 5% CO2 for
up to four weeks. The agar plates were reg-
ularly checked every 3 to 4 days. Identifi-
cation of Bartonella-suspected colonies
was based on morphological characteristics
and growth time on agar plates. The number
of colonies formed on the agar plates was
then recorded, and colony-forming units
(CFU) per milliliter of blood were calcu-
lated to represent the level of bacteremia.
When the visible colonies were identified,
they were subcultured and confirmed as
Bartonella at the species level by molecular
methods as mentioned above. The original
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isolates and their subcultures were frozen at
–70 °C for future usage.
2.5. Molecular identification of 
Bartonella species and 16S rRNA 
genotyping
Three to five colonies suspected to be
Bartonella spp. were harvested for identi-
fication of Bartonella species by PCR of the
citrate synthase gene (gltA gene) with one
set of specific primers, namely BhCS.781
(5’-GGG GAC CAG CTC ATG GTG G-3’)
and BhCS.1137n (5’-AAT CGA AAA
AGA ACA GTA AAC A-3’). The PCR
products were further processed by restric-
tion fragment length polymorphism
(RFLP) analysis with Taq I (Biolabs® Inc.,
USA) and Hha I (Takara Biochemicals,
Ohotsu, Japan) digestion [31]. Genomic
DNA was obtained by boiling bacterial col-
onies at 100 °C for 10 min. The template
DNA was mixed with the reaction solution
(10 mM Tris-HCl, pH 9.0, 50 mM KCl,
3 mM MgCl2, 0.01% (w/v) gelatin, 0.1%
Triton X-100) containing 1 mM of dNTPs,
20 pmol each of sense/antisense primers,
1.25 mg bovine serum albumin (BSA,
SIGMA, St. Louis, MO, USA), and 2.5 U
of Taq polymerase (GeneTeks BioScience
Inc., Germany), and adjusted to a final vol-
ume of 50 µL. DNA amplification was per-
formed with PCRExpress thermo cycler
(HYBAID) with initial denaturation (95 °C,
5 min), followed 35 cycles of denaturation
(95 °C, 1 min), annealing (55 °C, 30 s) and
extension (72 °C, 2 min), with a single final
extension step (72 °C, 5 min). The amplified
fragment (379 bp) was subjected to electro-
phoresis in a 3% agarose (NuSieve® 3:1
agarose, BioWhittaker Molecular Applica-
tions, Rockland, ME, USA) gel and stained
with 0.6 µg/mL ethidium bromide solution.
After confirmation by electrophoresis, the
amplicon was digested with TaqI and HhaI
restriction endonucleases. The isolates
were identified as B. henselae or B. clar-
ridgeiae by comparing the standard band
patterns of the type strains, B. henselae
Houston-1 (American Type Culture Collec-
tion, ATCC 49882) and B. clarridgeiae
(ATCC 51734).
Genotyping of B. henselae was per-
formed by PCR of the 16S rRNA gene as
previously described by Bergmans et al. [2]
with minor modifications. The reaction
solution of PCR was prepared with two sets
of B. henselae 16S rRNA gene type-specific
primers: 16SF and either BH1 or BH2.
DNA amplification was performed with
PCRExpress thermo cycler with initial
denaturation (95 °C, 3 min), followed
30 cycles of denaturation (95 °C, 20 s),
annealing (56 °C, 30 s) and extension
(73 °C, 1 min), with a single final extension
step (73 °C, 5 min). Amplified products
were subjected to electrophoresis in a 3%
agarose gel and the gel was stained with
0.6 µg/mL ethidium bromide solution.
When the specific band of 185 bp was
observed with primers 16SF and BH1, the
strain was identified as type I. While the
specific band of 185 bp was observed with
primers 16SF and BH2, the strain was iden-
tified as type II. The strains Houston-1 and
U-4 were used as the reference strains of
B. henselae types I and II, respectively. Strain
U-4 was kindly shared by Dr Bruno B. Chomel
(University of California, Davis, USA).
2.6. B. henselae indirect 
immunofluorescence antibody test
The antibody titers to B. henselae were
determined by indirect immunofluores-
cence antibody test (IFA), using slides
respectively made by B. henselae Houston-1
(ATCC 49882) and B. henselae U4 (Uni-
versity of California, Davis) as antigens
[32]. The type strain was cultured on choc-
olate agar plate at 37 °C in 5% CO2 for
4 days to grow up a confluent plate of bac-
teria. The cultured organisms harvested from
agar plates were suspended in 0.5 mL phos-
phate buffer saline (PBS, pH 7.4) and added
into 15 mL M199 tissue culture media
(SIGMA) with 5% fetal bovine serum
(FBS, HyClone® Laboratories Inc., Logan,
UT, USA). The bacteriological suspension
was inoculated to a 90% confluent Vero cell
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(CCRC 60013, Bioresources Collection
and Research Center, Taiwan) tissue cul-
ture flask (75 cm2) and incubated at 37 °C
with 5% CO2 for 2 days. After incubation,
the tissue culture was washed twice with
sterile calcium- and magnesium-free PBS,
and then was treated with trypsin for har-
vesting the infected cells. After using sterile
PBS to re-suspended cells, the suspension
was centrifuged at 200× g for 10 min. Then,
the supernatant was discarded and the cells
were resuspended in 30 mL growth medium
for tissue culture. A volume of 30 µL of sus-
pension containing infected cell was dis-
tributed onto each well of 12-hole Teflon
printed slides (Electron Microscopy Sci-
ence, Hatfield, PA, USA), and the slides
were incubated at 37 °C with 5% CO2 over-
night. After incubation, the slides were
washed twice in PBS, then fixed in acetone
and air-dried. The slides were put at –70 °C
for storage. 
For IFA testing, the frozen sera were
thawed at room temperature and treated at
56 °C for 30 min for heat inactivation. The
serum samples were serially diluted from
1:32 to 1:512 by twofold dilutions using
PBS (with 10% skim milk). Thirty micro-
liters of diluted serum was dropped onto
each well of slides previously prepared. The
slides were incubated at 37 °C for 40 min
and washed with PBS for 10 min. The sec-
ondary antibodies used for serological test-
ings in humans and cats were fluorescein-
labeled goat anti-human immunoglobulin
G and goat anti-cat immunoglobulin G
(Kirkegaard® Perry Laboratories Inc.,
Gaithersburg, MD, USA), respectively.
They were diluted at 1:400 in PBS, and the
mixture was applied to each well. The slides
were incubated at 37 °C for 40 min, washed
with PBS for 10 min, and washed again
with double distilled water for 10 min prior
to reading with a fluorescent microscope
(magnification, ×400). The intensity of the
bacillus-specific fluorescence was scored
subjectively from 1 to 4, and the fluores-
cence score of  ≥ 2 at dilution of 1:64 was
considered to be positive. The seronegative
cats were tested by IFA using B. henselae
U4 as the antigen.
2.7. Statistical analysis
The data were analyzed by SAS® version
6.12 and Microsoft Excel. The chi-square
test for homogeneity was used to evaluate
the association between disease status (bac-
teremia or seropositivity) and a categorized
risk factor, and P value was calculated using
Yates corrected method or two-tailed
Fisher’s exact test when expected numbers
of observations were less than five.
3. RESULTS
In the veterinary-associated population,
5 (1.7%) of the 295 persons were seropos-
itive for B. henselae. All five seropositive
individuals had recalled cat or dog expo-
sures during the last 6 months. No major
risk factors that we investigated were asso-
ciated with seropositivity to B. henselae.
Univariate analysis by Fisher exact test
showed that residence was the only factor
associated with seropositivity for B. hense-
lae (P < 0.05) (Tab. I). However, it was
observed that only a few samples were from
the eastern area of Taiwan. None of the 107
human blood specimens tested were PCR-
positive, but 5 of them were seropositive for
Bartonella. Their antibody titers were all at
1:64, which implied past infection.
Bartonella species were successfully
isolated from 25 (19%) of the 131 cats tested
(Tab. II). These isolates were confirmed to
be Bartonella species by PCR/RFLP of the
citrate synthase (gltA) gene with TaqI and
HhaI digestion. Comparing to the PCR/
RFLP patterns of the reference strains, it
was identified that one isolate was B. clar-
ridgeiae, and 24 isolates were B. henselae
(Fig. 1). B. henselae isolates were further
genotyped by PCR of the 16S rRNA gene.
Because there were two samples with major
fungal contamination that could not be ana-
lyzed by genotyping of 16S rRNA gene, the
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Table I. Distribution of Bartonella henselae seroprevalences according to different demographic
information in 295 veterinary-associated individualsa.
Variable No. of peoplea No. of seropositive cases (%) P-valueb
Gender 0.655
Male 168 2 (1.2)
Female 127 3 (2.4)
Age (y) 0.715
< 20 10 0 (0.0)
21–30 94 3 (3.2)
31–40 49 1 (2.0)
41–50 28 0 (0.0)
> 50 14 1 (7.1)
Occupation 0.890
Clinician 108 3 (2.8)
Veterinary technician 25 0 (0.0)
Public health veterinarian 24 0 (0.0)
Veterinary student 128 2 (1.6)
Staff 10 0 (0.0)
Residential area in Taiwan 0.022
Northern 158 2 (1.3)
Middle 115 1 (0.9)
Southern 19 1 (5.3)
Eastern 3 1 (33.3)
Clinic work experience (year) 0.081
0–3 124 2 (1.6)
4–10 37 2 (5.4)
11–20 25 0 (0.0)
21–30 4 1 (25.0)
> 30 4 0 (0.0)
Scratch or bite incidents in last 6 
months
0.162
Yes 125 5 (4.0)
No 70 0 (0.0)
Stray animal exposure 1.000
Yes 88 3 (3.4)
No 80 2 (2.5)
Cat/dog at home
Yes 161 5 (3.1) 0.589
No 34 0 (0.0)
a No. of people in each variable may not fulfill a total of 295 because of incomplete responses.
b Fisher’s exact test for homogeneity.
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results showed that at least 29.2% (7/24)
and 12.5% (3/24) of B. henselae bacteremic
cats were only infected with B. henselae
genotypes I or II, respectively. Interest-
ingly, at least 50% (12/24) of B. henselae-
infected cats were found to be co-infected
Table II. Comparison of Bartonella bacteremic status and seropositivity using B. henselae Houston-1 as
the antigen.
Bacteremic status No. of cats No. of seropositive cats (%)
B. henselae 24 12 (50.0)
    Type I only 7 6 (85.7)
    Type II only 3 0 (0.0)
    Co-infection of type I and type II 12 4 (33.3)
    Type unidentifiable (fungal contamination) 2 2 (100)
B. clarridgeiae 1a 0 (0.0)
Total 25 12 (48.0)
a
 The cat was co-infected with B. henselae type II.
Figure 1. PCR/RFLP of the gltA gene for the cat isolates: (a) with Hha I digestion; (b) with Taq I
digestion. M: standard 100-bp molecular ladder; lane 1: B. henselae ATCC 49882; lane 2:
B. clarridgeiae ATCC 51734; Negative control: lane 4 of (a) and lane 16 of (b); the other lanes were
isolates from cats tested (lane 3 is the cat positive for B. clarridgeiae and the other 12 lanes are
B. henselae positive cats).
572 C.-C. Chang et al.
with genotypes I and II (Fig. 2). It was identified
that one cat was dually-infected by B. clar-
ridgeiae and B. henselae type II (Tab. II).
The bacteremia level varied from 30 to
115 000 CFU/mL. Fifteen of the 25 bacter-
emic cats were found to have high level of
bacteremia (> 1000 CFU/mL). Most of the
bacteremic cats were male (60.0%), adult
(88.0%), with flea infestation (88.0%) and
impounded cats (80.0%) (Tab. III). According
to observation by investigators, flea infes-
tation rates varied in cats from origins, rang-
ing from 79.9% in impounded cats, 46.7%
in pet cats, and 0% in cats from the cat farm.
Thirty-one (23.7%) cats were seroposi-
tive for B. henselae. The geometric mean
titer of the cats tested was 1:128. By
univariate analysis (Tab. III), cats with flea
infestation were more likely to be bactere-
mic and seropositive for Bartonella
(P < 0.05). Cat origin was significantly
associated with seropositivity and bactere-
mia status. Impounded cats had the highest
percentages of seropositivity and bactere-
mia, followed by owners’ cats and then cats
from cat farm. None of the cats from the cat
farm were seropositive nor bacteremic for
Bartonella. Although gender was not a sta-
tistically significant factor associated with
bacteremia status, male cats were 2.34
times more likely to be bacteremic than
female cats. Although there was no signif-
icant association (correlation coefficient =
–0.021, P > 0.05) between B. henselae anti-
body titer and bacteremia level, it was found
that seropositive cats were more likely to be
Bartonella bacteremic than seronegative
cats (38.7% vs. 13.0%, P < 0.05). Further-
more, it was found that more than half (13/
25) of bacteremic cats did not raise antibod-
ies against to B. henselae Houston-1,
mainly in cats infected with only B. hense-
lae type II (3/3) and with B. clarridgeiae
infection (1/1) and with B. henselae types I
and II co-infection (8/12) (Tab. II). When
these 12 bacteremic but seronegative cats
were re-tested by IFA slides coated with
type II antigen (B. henselae U-4, University
of California, Davis, USA), 9 cats were
identified to be seropositive, with ranges of
antibody titers from 1:128 to 1:1024.
To evaluate the validity of direct PCR
detection for determination of bacteremic
status, 44 cats were blindly chosen for
Figure 2. Using 16S rRNA gene for genotyping of B. henselae: (a) cats infected with genotype I;
(b) cats infected with genotype II; M: standard 100-bp molecular ladder; lane 1: B. henselae ATCC
49882; lane 2: B. henselae U-4 strain; lane 3: negative control; the other lanes were isolates from
cats tested.
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comparison. The sensitivity and specificity
of direct PCR test of the 16S-23S rRNA
intergenic region were 60% (3/5) and 67%
(26/39), respectively. The PCR test was
with low positive predictive value of 19%
(3/16) and high negative predictive value of
93% (26/28). Further using the combination
of IFA test and direct PCR test to determine
bacteremic status, it was found that 96%
(25/26) of the cats with negative results by
both IFA and direct PCR test were non-bac-
teremic (Tab. IV). 
4. DISCUSSION
This is the first epidemiologic study of
Bartonella infection in veterinary profes-
sionals and cats in Taiwan, since the first
human CSD case reported in 1998 [22]. The
seroprevalence of B. henselae was 1.7% in
veterinary-associated individuals. This prev-
alence was lower than in previous reports
from Japan, which were 15% in veterinary
professionals [20] and 10.9% in veterinary
school students [17]. It was also lower than
the 7.1% in the veterinary population that
attended the veterinary Conference in Ohio,
USA [30]. Because of the low seropreva-
lence of B. henselae in humans in our study,
no significant risk factors were identified to
be associated with the infection. Neverthe-
less, through clinical interviews, all of the
five seropositive individuals had a history
of animal bite or scratch incidents during
the previous 6 months before this survey.
Therefore, knowing how to handle animals
properly seems to be an important way to
reduce the risk of getting CSD infection in
Taiwan.
Table III. Univariate analysis of the characteristics of cats associated with Bartonella bacteremia and
seropositivity.
Variable No. of cats No. of seropositive cats (%) No. of cats with bacteremia (%)
Gender
    Male 49 11 (22.4) 15 (30.6)
    Castrated male 10 2 (20) 0 (0)
    Female 61 17 (27.9) 8 (13.1)
    Unknown 11 1 (9.1) 2 (18.1)
Age
    Adult 114 27 (23.7) 22 (19.3)
    Juvenile 17 4 (23.5) 3 (17.6)
Flea infestation
    Yes 65 23 (35.4)a 22 (33.8)a
    No 66 8 (12.1) 3 (9.1)
Holding condition 
    Owner’s pet 30 8 (26.7) 5 (16.7)
    Cat farm 37 0 (0) 0 (0)
    Impounded cats 64 23 (40) 20 (31.3)
Total 131 31 (23.7) 25 (19.1)
a
 P < 0.05 by Fisher’s exact test for homogeneity.
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The overall prevalences of seropositivity
and bacteremia in cats in Taiwan were
23.7% and 19.1%, respectively. Our data
further indicated that Bartonella seroposi-
tivity ranged from 0% to 16.7% in pet cats
and 31.3% in impounded cats. Comparing
to the results in other Asian countries, the
prevalence of Bartonella bacteremia in cats
in Taiwan was between that in Japan (7.2–
9.1%) [25, 26], and in the Philippines (61%)
[8]. The study subjects in Japan were mainly
pet cats; however, only stray cats were
investigated in Philippines [8, 25, 26]. Prev-
alence of Bartonella infection in cats has
been shown to be associated with climatic
factors in the USA [15] and Japan [28]. That
is, high seroprevalence of the infection in
cats correlates with warm and humid cli-
mates. As Bartonella infections are mainly
transmitted by arthropods, it was hypothe-
sized that climatic factors may affect the
distribution of arthropod vectors, including
fleas. Our data further suggested that the
prevalence of Bartonella infection in Asian
cats was associated with countries with dif-
ferent latitudes, from the lowest prevalence
in the temperate country (e.g. Japan), the
moderate in the sub-tropical country (e.g.
Taiwan) and the highest in the tropical
country (e.g. Philippines). 
Similar to the previous reports from
other countries [3, 6, 8], cats with Bar-
tonella bacteremia was strongly associated
with flea infestation in our study. In Japan,
the prevalence of B. henselae in flea-
infested cats was significantly higher than
that of flea-free individuals [28]. Owing to
the humid and warm climate in Taiwan, the
flea infestation rates were 79.9% and 46.7%
in the impounded cats and in the owners’
cats in our study, respectively. Among cats
from a breeding farm with strict ectopara-
site control, none of them were seropositive
or bacteremic for Bartonella. The results
highlight the importance of flea control in
cats to prevent the disease transmission in
Taiwan.
Among the 25 bacteremic cats, ten cats
were identified to be only infected with
B. henselae type I (7 cats) or type II (3 cats).
However, 12 cats were co-infected with
B. henselae type I and type II. This is the
highest prevalence (9.2%, 12/131) of co-
infection with B. henselae type I and type II
in cat population that has ever been reported
worldwide [4, 13, 27]. In most Asian coun-
tries, B. henselae isolates from cats belong
predominantly to type I , even if the number
of cats tested is rather small [5, 26, 27]. Sim-
ilarly, we identified a higher proportion of
Bartonella-bacteremic cats with B. hense-
lae type I infection than type II infection. 
Yamamoto et al. [35], reported that cats
primarily infected with B. henselae type I
and challenged with B. henselae type II
showed cross-protection from bacteremia,
whereas no cross-protection was previously
shown for cats primarily infected with
B. henselae type II and challenged with
B. henselae type I [34]. Therefore, it would
be reasonable to hypothesize that antibodies
against the antigens of B. henselae type II
might not reacted with the antigens of
B. henselae type I.  Previous reports [11, 21]
have also shown that cats with B. henselae
type II or B. clarridgeiae bacteremia could
Table IV. Evaluation of serodiagnosis and PCR method to determine cats with bacteremia.
No. of cats with bacteremia No. of cats without bacteremia
Sero-negative and PCR-negative 1 25
Sero-negative but PCR-positive 2 12
Sero-positive but PCR-negative 1 1
Sero-positive and PCR-positive 1 1
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be seronegative by IFA when using
B. henselae Houston-1 as the antigen. The
same results were also identified in our
study. Therefore, using B. henselae Hou-
ston-1 only as the antigen for sero-diagnosis
would underestimate the number of seropos-
itive cats with B. henselae type II infection. 
A valid test for CSD diagnosis in cats is
important for prevention of the disease
transmission. Our results indicated that sig-
nificant association between seropositivity
and bacteremic status, while IFA test was
with low positive predictive value (42%)
and moderate negative predictive value
(86%). Nowadays, PCR machines are avail-
able almost in every diagnostic laboratory.
Molecular identification of Bartonella DNA
using whole blood samples may offer quick
reference data. We found direct PCR test of
16S-23S intergenic region offers 93% neg-
ative predictive value for determining Bar-
tonella non-bacteremic cats. If the cat was
both PCR and IFA negative, the probability
of being a non-bacteremic cat could be even
higher (with a negative predictive value of
96%). Clinically, it seems to be a feasible
way to determine Bartonella-free cats from
unknown origins.
In conclusion, the study implied the
importance of stray cat control in Taiwan
for CSD prevention, on the basis of high
prevalence of Bartonella bacteremia in this
population. Although the seroprevalence of
CSD was not high in the veterinary popu-
lations that we investigated, people still
need to be aware of acquiring the infection
through accidental transmission from stray
cats living close to human environments.
ACKNOWLEDGEMENTS
This study was supported in part by grants
DOH92-DC-1074 and DOH91-DC-1068 (to Dr
Ming Jen Pan) from the Center for Disease Con-
trol, Department of Health, Taiwan, ROC, and
NSC91-2320-B-039-019 (to Dr Chao-chin Chang)
from the National Science Council, Taiwan,
ROC.
REFERENCES
[1] Anderson B., Kelly C., Threlkel R., Edwards
K., Detection of Rochalimaea henselae in
cat-Scratch disease skin test antigens, J.
Infect. Dis. 168 (1993) 1034–1036.
[2] Bergmans A.M.C., Schellekens J.F.P., van
Embden J.D.A., Schouls L.M., Predomi-
nance of two Bartonella henselae variants
among cat scratch disease patients in the
Netherlands, J. Clin. Microbiol. 34 (1996)
254–260.
[3] Bergmans A.M., de Jong C.M., van
Amerongen G., Schot C.S., Schouls L.M.,
Bergmans A.M., Schellekens J.F., van
Embden J.D., Schouls L.M., Prevalence of
Bartonella species in domestic cats in the
Netherlands, J. Clin. Microbiol. 35 (1997)
2256–2261.
[4] Birtles R.J., Laycock G., Kenny M.J., Shaw
S.E., Day M.J., Prevalence of Bartonella spe-
cies causing bacteremia in domesticated and
companion animals in the United Kingdom,
Vet. Rec. 151 (2002) 225–229.
[5] Boulouis H.J., Chang C.C., Henn J.B., Kasten
R.W., Chomel B.B., Factors associated with
the rapid emergence of zoonotic Bartonella
infections, Vet. Res. 36 (2005) 383–410.
[6] Chomel B.B., Abbott R.C., Kasten R.W.,
Floyd-Hawkins K.A., Kass P.H., Glaser
C.A., Pedersen N.C., Koehler J.E., Bar-
tonella henselae prevalence in domestic cats
in California: risk factors and association
between bacteremia and antibody titers, J.
Clin. Microbiol. 33 (1995) 2445–2450.
[7] Chomel B.B., Kasten R.W., Floyd-Hawkins
K., Chi B., Yamamoto K., Roberts-Wilson J.,
Gurfield A.N., Abbott R.C., Pedersen N.C.,
Koehler J.E., Experimental transmission of
Bartonella henselae by the cat flea, J. Clin.
Microbiol. 34 (1996) 1952–1956.
[8] Chomel B.B., Carlos E.T., Kasten R.W.,
Yamamoto K., Chang C.C., Carlos R.S.,
Abenes M.V., Pajares C.M., Bartonella
henselae and Bartonella clarridgeiae infec-
tion in domestic cats from the Philippines,
Am. J. Trop. Med. Hyg. 60 (1999) 593–597.
[9] Demers D.M., Bass J.W., Vincent J.M., Person
D.A., Noyes D.K., Staege C.M., Samlaska
C.P., Lockwood N.H., Regnery R.L., Anderson
B.E., Cat-scratch disease in Hawaii: etiology
and seroepidemiology, J. Pediatr. 127 (1995)
23–26.
[10] Dolan M.J., Wong M.T., Regnery R.L.,
Jorgensen J.H., Garcia M., Peters J., Drehner
D., Syndrome of Rochalimaea henselae
576 C.-C. Chang et al.
adenitis suggesting cat scratch disease, Ann.
Intern. Med. 118 (1993) 331–336.
[11] Drancourt M., Birtles R., Chaumentin G.,
Vandenesch F., Etienne J., Raoult D., New
serotype of Bartonella henselae in endocar-
ditis and cat-scratch disease, Lancet 347
(1996) 441–443.
[12] Foil L., Andress E., Freeland R.L., Roy A.F.,
Rutledge R., Triche P.C., O'Reilly K.L.,
Experimental infection of domestic cats with
Bartonella henselae by inoculation of Cteno-
cephalides felis (Siphonaptera: Pulicidae)
feces, J. Med. Entomol. 35 (1998) 625–628.
[13] Gurfield A.N., Boulouis H.J., Chomel B.B.,
Heller R., Kasten R.W., Yamamoto K., Piemont
Y., Coinfection with Bartonella clarridgeiae
and Bartonella henselae and with different
Bartonella henselae strains in domestic cats,
J. Clin. Microbiol. 35 (1997) 2120–2123.
[14] Higgins J.A., Radulovic S., Jaworski D.C.,
Azad A.F., Acquisition of the cat scratch dis-
ease agent Bartonella henselae by cat fleas
(Siphonaptera: Pulicidae), J. Med. Entomol.
33 (1996) 490–495.
[15] Jameson P., Greene C., Regnery R., Dryden
M., Marks A., Brown J., Cooper J., Glaus B.,
Greene R., Prevalence of Bartonella hense-
lae antibodies in pet cats throughout regions
of North America, J. Infect. Dis. 172 (1995)
1145–1149.
[16] Jensen W.A., Fall M.Z., Rooney J., Kordick
D.L., Breitschwerdt E.B., Rapid identifica-
tion and differentiation of Bartonella species
using a single-step PCR assay, J. Clin. Micro-
biol. 38 (2000) 1717–1722.
[17] Kikuchi E., Maruyama S., Sakai T., Tanaka
S., Yamaguchi F., Hagiwara T., Katsube Y.,
Mikami T., Serological investigation of Bar-
tonella henselae infections in clinical cat-
scratch disease-suspected patients, patients
with cardiovascular disease, and healthy vet-
erinary students in Japan, Microbiol. Immu-
nol. 46 (2002) 313–316.
[18] Koehler J.E., Glaser C.A., Tappero J.W.,
Rochalimaea henselae infection – a new zoo-
nosis with the domestic cat as reservoir, J.
Am. Med. Assoc. 271 (1994) 531–535.
[19] Kordick D.L., Hilyard E.J., Hadfield T.L.,
Wilson K.H., Steigerwalt A.G., Brenner D.J.,
Breitschwerdt E.B., Bartonella clarridgeiae,
a newly recognized zoonotic pathogen caus-
ing inoculation papules, fever, and lymphad-
enopathy (cat scratch disease), J. Clin.
Microbiol. 35 (1997) 1813–1818.
[20] Kumasaka K., Arashima Y., Yanai M.,
Hosokawa N., Kawano K., Survey of veteri-
nary professionals for antibodies to Bar-
tonella henselae in Japan, Rinsho Byori 49
(2001) 906–910.
[21] La Scola B., Davoust B., Boni M., Raoult D.,
Lack of correlation between Bartonella DNA
detection within fleas, serological results,
and results of blood culture in a Bartonella-
infected stray cat population, Clin. Micro-
biol. Infect. 8 (2002) 345–351.
[22] Lee S.C., Fung C.P., Lee N., Shieh W.B.,
Cat-scratch disease caused by Bartonella
henselae: the first case report in Taiwan, J.
Formos. Med. Assoc. 97 (1998) 569–572.
[23] Margileth A.M., Baehren D.F., Chest-wall
abscess due to cat-scratch disease (CSD) in
an adult with antibodies to Bartonella clar-
ridgeiae: case report and review of the tho-
racopulmonary manifestations of CSD, Clin.
Infect. Dis. 27 (1998) 353–357.
[24] Marston E.L., Finkel B., Regnery R.L.,
Winoto I.L., Graham R.R., Wignal S.,
Simanjuntak G., Olson J.G., Prevalence of
Bartonella henselae and Bartonella clar-
ridgeiae in an urban Indonesian cat population,
Clin. Diagn. Lab. Immunol. 6 (1999) 41–44.
[25] Maruyama S., Nogami S., Inoue I., Namba
S., Asanome K., Katsube Y., Isolation of
Bartonella henselae from domestic cats in
Japan, J. Vet. Med. Sci. 58 (1996) 81–83.
[26] Maruyama S., Nakamura Y., Kabeya H.,
Tanaka S., Sakai T., Katsube Y., Prevalence
of Bartonella henselae, Bartonella clar-
ridgeiae, and the 16S rRNA gene types of
Bartonella henselae among pet cats in Japan,
J. Vet. Med. Sci. 62 (2000) 273–279.
[27] Maruyama S., Sakai T., Morita Y., Tanaka S.,
Kabeya H., Boonmar S., et al., Prevalence of
Bartonella species and 16s rRNA gene types
of Bartonella henselae from domestic cats in
Thailand, Am. J. Trop. Med. Hyg. 65 (2001)
783–787.
[28] Maruyama S., Kabeya H., Nakao R., Tanaka
S., Sakai T., Katsube Y., Mikami T., Sero-
prevalence of Bartonella henselae, Toxo-
plasma gondii, FIV and FeLV infections in
domestic cats in Japan, Microbiol. Immunol.
47 (2003) 147–153.
[29] Nasirudeen A.M.A., Thong M.L., Preva-
lence of Bartonella henselae immunoglobu-
lin G antibodies in Singaporean cats, Pediatr.
Infect. Dis. J. 18 (1999) 276–278.
[30] Noah D.L., Kramer C.M., Verbsky M.P.,
Rooney J.A., Smith K.A., Childs J.E., Survey
of veterinary professionals and other veteri-
nary conference attendees for antibodies to
Cat-scratch disease in Taiwan 577
Bartonella henselae and B. quintana, J. Am.
Vet. Med. Assoc. 210 (1997) 342–344.
[31] Norman A.F., Regnery R., Jameson P.,
Greene C., Krause D.C., Differentiation of
Bartonella-like isolates at the species level
by PCR-restriction fragment length polymor-
phism in the citrate synthase gene, J. Clin.
Microbiol. 33 (1995) 1797–1803.
[32] Regnery R.L., Olson J.G., Perkins B.A., Bibb
W., Serological response to “Rochalimaea
henselae” antigen in suspected cat-scratch
disease, Lancet 339 (1992) 1443–1445.
[33] Szelc-Kelly C.M., Goral S., Perez-Perez G.I.,
Perkins B.A., Regnery R.L., Edwards K.M.,
Serologic responses to Bartonella and Afipia
antigens in patients with cat scratch disease,
Pediatrics 96 (1995) 1137–1142.
[34] Yamamoto K., Chomel B.B., Kasten R.W.,
Chang C.C., Tseggai T., Decker P.R.,
Mackowiak M., Floyd-Hawkins K.A.,
Pedersen N.C., Homologous protection but
lack of heterologous protection by various
species and types of Bartonella in specific
pathogen free cats, Vet. Immunol. Immun-
opathol. 65 (1998) 191–204.
[35] Yamamoto K., Chomel B.B., Kasten R.W.,
Hew C.M., Weber D.K., Lee W.I., Koehler
J.E., Pedersen N.C., Infection and re-infec-
tion of domestic cats with various Bartonella
species and types: B. henselae type I is pro-
tective against heterologous challenge with
B. henselae type II, Vet. Microbiol. 92 (2003)
73–86.
[36] Ueno H., Muramatsu Y., Chomel B.B.,
Hohdatsu T., Koyama H., Morita C., Seroep-
idemiologic survey of Bartonella (Rochali-
maea) henselae in domestic cats in Japan,
Microbiol. Immunol. 39 (1995) 339–341.
To access this journal online: 
www.edpsciences.org
